Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation

This publication has 30 references indexed in Scilit:

• Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis – are there new strategies?
  Bone Marrow Transplantation, 1999
• Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors
  Bone Marrow Transplantation, 1999
• A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: A focus on the incidence of graft-vs.-host disease and relapse
  Transplantation and Cellular Therapy, 1999
• Blood and marrow transplantation activity in Europe 1996
  Bone Marrow Transplantation, 1998
• Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow
  Bone Marrow Transplantation, 1998
• Filgrastim fails to improve haemopoietic reconstitution following myeloablative chemotherapy and peripheral blood stem cell rescue
  British Journal of Cancer, 1994
• Randomized study of growth factors post-peripheral-blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit.
  Journal of Clinical Oncology, 1994
• Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation
  The Lancet, 1994
• Phase I/II trial of recombinant human granulocyte-macrophage colony- stimulating factor following allogeneic bone marrow transplantation
  Blood, 1991
• Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trial
  The Lancet, 1990